(a) The research MUST address the issue of multimorbidity, specifically amongst BAME adults diagnosed with diabetes, who are also multimorbid, or have a high risk of multimorbidity.
(b) The research must be made available and accessible to the BAME community, particularly BAME adults with (or at risk of) diabetes-related multimorbidity. The researchers will be required to avoid basic roadblocks to “knowledge transfer” that hamper dissemination, such as: (1) findings delivered solely through journal articles and static tables that take effort for policymakers and the general public to find and interpret; and (2) important research languishing for considerable time—often years—before it can be published and reach the intended audience.
(c) The research MUST be for the public benefit, specifically the relief of sickness and the promotion and protection of good health amongst BAME individuals suffering from diabetes and who are also multimorbid or are at risk of becoming multimorbid.
(d) Regarding commercialisation (sponsored collaborations, contract research, joint ventures), the trustees will require that any research carried out in collaboration with a commercial organisation, must NOT be a sponsored collaboration. Contract research and joint ventures are acceptable.
(e) The trustees will only support collaborative research with scope beyond the charity’s objects provided the charity’s resources are used solely to support aspects of the project relating to the objects.